Works matching IS 01145916 AND DT 2022 AND VI 45 AND IP 8

Results: 11

Authors' Reply to Mungmunpuntipantip et al.'s Comment on "Description of Frequencies of Reported Adverse Events Following Immunization Among Four Different COVID-19 Vaccine Brands".

Published in:

Drug Safety, 2022, v. 45, n. 8, p. 925, doi. 10.1007/s40264-022-01207-x

By:

Kant, Agnes;
van Hunsel, Florence

Publication type:

Article

A Review of Causal Inference for External Comparator Arm Studies.

Published in:

2022

By:

Rippin, Gerd;
Ballarini, Nicolás;
Sanz, Héctor;
Largent, Joan;
Quinten, Chantal;
Pignatti, Francesco

Publication type:

journal article

Comment on "Description of Frequencies of Reported Adverse Events Following Immunization Among Four Different COVID-19 Vaccine Brands".

Published in:

2022

By:

Mungmunpuntipantip, Rujittika;
Wiwanitkit, Viroj

Publication type:

Letter to the Editor

Developing Strategic Recommendations for Implementing Smart Pumps in Advanced Healthcare Systems to Improve Intravenous Medication Safety.

Published in:

2022

By:

Sutherland, Adam;
Jones, Matthew D.;
Howlett, Moninne;
Arenas-Lopez, Sara;
Patel, Arif;
Franklin, Bryony Dean

Publication type:

journal article

Kidney Damage and Stress Biomarkers for Early Identification of Drug-Induced Kidney Injury: A Systematic Review.

Published in:

2022

By:

Desai, Ravi J.;
Kazarov, Christina L.;
Wong, Adrian;
Kane-Gill, Sandra L.

Publication type:

journal article

Safety of Praziquantel and Albendazole Coadministration for the Control and Elimination of Schistosomiasis and Soil-Transmitted Helminths Among Children in Rwanda: An Active Surveillance Study.

Published in:

2022

By:

Kabatende, Joseph;
Barry, Abbie;
Mugisha, Michael;
Ntirenganya, Lazare;
Bergman, Ulf;
Bienvenu, Emile;
Aklillu, Eleni

Publication type:

journal article

A Disproportionality Analysis of Drug-Drug Interactions of Tizanidine and CYP1A2 Inhibitors from the FDA Adverse Event Reporting System (FAERS).

Published in:

Drug Safety, 2022, v. 45, n. 8, p. 863, doi. 10.1007/s40264-022-01200-4

By:

Villa-Zapata, Lorenzo;
Gómez-Lumbreras, Ainhoa;
Horn, John;
Tan, Malinda S.;
Boyce, Richard D.;
Malone, Daniel C.

Publication type:

Article

Correction to: Machine Learning in Causal Inference: Application in Pharmacovigilance.

Published in:

2022

By:

Zhao, Yiqing;
Yu, Yue;
Wang, Hanyin;
Li, Yikuan;
Deng, Yu;
Jiang, Guoqian;
Luo, Yuan

Publication type:

Correction Notice

Short-Term Risk of Unintentional Poisoning After New Initiation of Central Nervous System Medications in Swedish Older Adults: A Register-Based Case-Crossover Study.

Published in:

2022

By:

Zhao, Yang;
Liang, Yajun;
Laflamme, Lucie;
Rausch, Christian;
Johnell, Kristina;
Möller, Jette

Publication type:

journal article

Post-Marketing Surveillance of CAR-T-Cell Therapies: Analysis of the FDA Adverse Event Reporting System (FAERS) Database.

Published in:

Drug Safety, 2022, v. 45, n. 8, p. 891, doi. 10.1007/s40264-022-01194-z

By:

Fusaroli, Michele;
Isgrò, Valentina;
Cutroneo, Paola Maria;
Ferrajolo, Carmen;
Cirillo, Valentina;
Del Bufalo, Francesca;
Raschi, Emanuel;
Poluzzi, Elisabetta;
Trifirò, Gianluca

Publication type:

Article

Combining Machine Learning with a Rule-Based Algorithm to Detect and Identify Related Entities of Documented Adverse Drug Reactions on Hospital Discharge Summaries.

Published in:

2022

By:

Tan, Hui Xing;
Teo, Chun Hwee Desmond;
Ang, Pei San;
Loke, Wei Ping Celine;
Tham, Mun Yee;
Tan, Siew Har;
Soh, Bee Leng Sally;
Foo, Pei Qin Belinda;
Ling, Zheng Jye;
Yip, Wei Luen James;
Tang, Yixuan;
Yang, Jisong;
Tung, Kum Hoe Anthony;
Dorajoo, Sreemanee Raaj

Publication type:

journal article